Global Amniotic Products Market is estimated to grow at a 8% CAGR to reach $1 billion by 2026 - Multiple Benefits of Amniotic Membrane Transplantation & Applications of Dehydrated Amniotic Membranes

Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic which are considered a potential treatment option for augmentation of joint inflammation and healing. An amniotic membrane (AM) or amnion is a thin membrane forming a closed sac around the embryos or fetuses, and mammals and containing the amniotic fluid. The most common types of amniotic membranes used are cryopreserved amniotic membranes and lyophilized amniotic membranes. Today, all amniotic, placental, and umbilical tissue-based products are classified by the FDA as human tissue without living cells.

Adoption of Amniotic Based Products in Woundcare Healing

Amniotic membranes are made of structural collagen and extracellular matrix, regenerative, and biologically active cells, all of which interact with one another to regulate the healing processes. In the complex cascade of woundcare healing, a hallmark of a chronic non-healing wound is prolonged inflammation. This disrupts the healing cycle thus leading to a decrease in normal proliferation of growth factors as well as an imbalance in protective versus degradative enzymes favoring destruction of the extracellular matrix. Amniotic membrane can help facilitate woundcare healing by providing the major growth factors and other healing cascades which adhere to the extracellular matrix to enhance tissue growth and healing.

Growing Potential of Amniotic Membrane Products in Regenerative Medicines Fuels the Global Market Demand

Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering, and the production of artificial organs. The amniotic membrane (Amnio-M) finds several applications in regenerative medicine. It acts as a highly biocompatible natural scaffold and as a source of several types of stem cells and potent growth factors. The Amnio-M possess unique characteristics which render them useful in diverse applications such as the tracheal reconstruction of the fetus, restoration of the diaphragm muscles, bone grafts, heart valve leaflets, plantar fasciitis, osteoarthritis (OA), spinal cord regeneration, ophthalmologic disorders, and skin repair, among others.

"Amniotic-based products are upcoming products which are evolving significantly in various segments of medicine. Rapid progress has been made by researchers and scientists in the segment of biology and engineering to advance the understanding of tissue engineering & biomaterials to enable the development of new treatments that will lessen the burden of diseases." - Senior Director, Amniotic Products Company, United States

Geographic Analysis: North America holds the Larger Share of Amniotic Products Market

From a regional perspective, North America holds the larger share of the amniotic products market followed by Europe. Growing research activities, adoption of amniotic membranes for major applications, awareness on amniotic membrane transplants, and the presence of leading market players in this regions are some of the primary factors driving the growth of the amniotic products market.

Competitive Landscape Analysis: Amniotic Products Market

Some of the established market players operating in the global amniotic products market are MiMedx, Smith & Nephew, Organogenesis Inc., Integra Lifesciences, and Applied Biologics, among others.

Get Detailed Insights on Amniotic Products Market with a Sample Report PDF @ https://meditechinsights.com/amniotic-products-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.